CSPC Pharmaceutical Group (CSPCY) Insider Trading & Ownership → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free CSPCY Stock Alerts C$3.33 +0.01 (+0.30%) (As of 04/29/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartDividendInsider TradesShort InterestStock AnalysisChartDividendInsider TradesShort Interest There is no recent insider trading on record for CSPC Pharmaceutical Group, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get CSPCY Insider Trade Alerts Want to know when executives and insiders are buying or selling CSPC Pharmaceutical Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Banyan Hill PublishingNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. CSPC Pharmaceutical Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction9/15/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$2.94$1,001 - $15,0007/14/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$3.20$1,001 - $15,0006/13/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$3.34$1,001 - $15,00012/30/2022Josh GottheimerU.S. Congress Member (D-NJ)Sell$4.08$1,001 - $15,0004/19/2022Josh GottheimerU.S. Congress Member (D-NJ)Buy$1,001 - $15,0003/15/2022Josh GottheimerU.S. Congress Member (D-NJ)Sell$1,001 - $15,0001/10/2022Josh GottheimerU.S. Congress Member (D-NJ)Buy$1,001 - $15,00012/9/2021Josh GottheimerU.S. Congress Member (D-NJ)Sell$1,001 - $15,0009/17/2021Josh GottheimerU.S. Congress Member (D-NJ)Buy$1,001 - $15,000 (Data available from 1/1/2013 forward) CSPCY Insider Trading Activity - Frequently Asked Questions Which members of congress are trading CSPC Pharmaceutical Group? Josh Gottheimer (D-NJ) has bought shares of CSPC Pharmaceutical Group in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $16,000. More Insider Trading Tools from MarketBeat Related Companies: Otsuka Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (OTCMKTS:CSPCY) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSPC Pharmaceutical Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
